18 F‐Fallypride: A Valuable Agent for Islet Cell‐Targeted Imaging
Organ Medicine · 2025
DOI: 10.1002/orm2.70009 ↗Abstract
ABSTRACT Background Islet dysfunction can lead to a wide range of digestive and endocrine disorders; therefore, the visual monitoring of islet cell function is of particular significance. We aim to evaluate the usefulness of the dopamine D2 receptor imaging agent (s)‐(−)‐ N ‐(1‐allylpyrrolidine‐2‐ N ‐methyl)‐5‐(3‐ 18 F)‐2,3‐dimethoxy‐benzamide ( 18 F‐fallypride) for islet cell‐targeted imaging. Methods We investigated the effect of different concentrations of the dopamine inhibitor droperidol on the binding of 18 F‐fallypride to islet cells. We calculated the cellular binding rate by incubating islet cells (1.5 × 10 4 cells/well) with 18 F‐fallypride (3.70 kBq). The rate of 18 F‐fallypride binding in six groups of islet cells treated with different concentrations of droperidol was measured, and the 18 F‐fallypride binding by the cells in relation to the inhibitor concentration was plotted. To further investigate the binding of 18 F‐fallypride to islet cells in vivo, six groups (A–F) of mice were set up. The groups were injected with 18 F‐fallypride 30 min before intravenous injection of different concentrations of droperidol. After a 10‐minute observation, the pancreas was dissected and sectioned for autoradiography. Finally, the grayscale of the pancreatic tissue was evaluated and quantified. The overall comparisons among all groups were done using single‐factor analysis of variance, and comparisons among groups were done using the least significant difference test. Results (1) The in vitro islet cell‐binding rate of 18 F‐fallypride was 18.4% ± 1.21%. The binding rates of the droperidol inhibition groups were 16.11% ± 1.37%, 15.76% ± 0.99%, 13.9% ± 1.02%, 8.86% ± 0.73%, 7.26% ± 0.62%, and 6.92% ± 0.58%. When the concentration of droperidol was 1.0 × 10 −4 M, the 18 F‐fallypride binding rate of islet cells was the lowest, and the inhibition rate was 51.85%. No significant difference was detected between the binding rates of the 5 × 10 −4 M and 1.0 × 10 −3 M droperidol groups ( p = 0.11 and 0.06). (2) The autoradiography showed that the pancreas grayscale of Group A (control) was 1.21 × 10 6 (DLU/mm 2 ). However, the pancreas grayscale levels of Groups B–F were 0.93 × 10 6 (DLU/mm 2 ), 0.77 × 10 6 (DLU/mm 2 ), 0.59 × 10 6 (DLU/mm 2 ), 0.32 × 10 6 (DLU/mm 2 ), and 0.25 × 10 6 (DLU/mm 2 ), respectively; namely, it decreased with increasing concentrations of the inhibitor. Conclusion 18 F‐fallypride specifically and efficiently binds to dopamine receptors on islet cells, and therefore presents as a promising novel radiotracer for islet cells imaging.
EUVIMED